3 results  1 of 1 

1 Biphasic anaphylaxis to gemifloxacin
İnsu Yilmaz, Serkan Doğan, Nuri Tutar, Asiye Kanbay, Hakan Büyükoğlan, Ramazan Demir
Asia Pac Allergy.2012;2(4):280-282.   Published online 2012 October 31     DOI: http://dx.doi.org/10.5415/apallergy.2012.2.4.280
      
2 In vitro Activity of Gemifloxacin Against Recent Clinical Isolates of Bacteria in Korea
Dong Eun Yong, Hee Jin Cheong, Yang Soo Kim, Yeon Joon Park, Woo Joo Kim, Jun Hee Woo, Kyung Won Lee, Moon Won Kang, Youn Sung Choo
J Korean Med Sci.2002;17(6):737-742.   Published online 2009 April 22     DOI: http://dx.doi.org/10.3346/jkms.2002.17.6.737
      
3 A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Korean Adult Population
Young Whan Kim, Young-Soo Shim, Won Dong Kim, Tae Sun Shim, Hong Mo Kang, ByoungWhui Choi, Jae-Yeol Kim, O Jung Kwon, Hojoong Kim, Ju Ock Kim, Ki-Suck Jung, In Gyou Hyeon, Eun Kyung Mo, Seung-Joon Lee, Gui Hyun Nam, Kye Young Lee, Jae Seuk Park
Tuberc Respir Dis.2003;55(1):69-87.   Published online 2003 July 31     DOI: http://dx.doi.org/10.4046/trd.2003.55.1.69
      

 1 of 1